According to Prof Watson: “Many therapies, devices and surgical procedures have been developed to treat keratoconus, but few have been evaluated using post-market surveillance, and there is no syst in place to collect such data nationally.”Keratoconus tends to affect young adults and has a significant public health impact”.The first treatment to be evaluated via the registry is cross-linking, a relatively-new approach to halting keratoconus progression.
Carrera celebrates milestone with limited-edition collection
To celebrate its 70th anniversary, Carrera has announced the introduction of an exclusive Made in Italy limited-edition capsule collection that...
